M. T. Labro
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Microbiology top 5%
Papers in
- Immunology 26
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 16
- Immune Response and Inflammation 14
- Pharmacology 19
- Antibiotics Pharmacokinetics and Efficacy 17
- Co-authors
- Houria Abdelghaffar (15 shared papers)C. Babin-Chevaye (13 shared papers)A. Bryskier (9 shared papers)El Mostafa Mtairag (3 shared papers)J Hakim (9 shared papers)Jean‐Claude Homberg (2 shared papers)Michel Weber (1 shared paper)Muriel Andrieu (1 shared paper)
In The Last Decade
M. T. Labro
57 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 95
- Molecular Medicine 215
- Microbiology 150
- Pharmacology 322
- Immunology 386
- Epidemiology 505
Countries citing papers authored by M. T. Labro
This map shows the geographic impact of M. T. Labro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. T. Labro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. T. Labro more than expected).
Fields of papers citing papers by M. T. Labro
This network shows the impact of papers produced by M. T. Labro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. T. Labro. The network helps show where M. T. Labro may publish in the future.
Co-authors
The 16 scholars most cited alongside M. T. Labro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 190 | |
| 2 | 2000 | 108 | |
| 3 | 1989 | 82 | |
| 4 | 2001 | 74 | |
| 5 | 1998 | 55 | |
| 6 | 1993 | 50 | |
| 7 | 1990 | 49 | |
| 8 | A new pattern of non-organ- and non-species-specific anti-organelle antibody detected by immunofluorescence: the mitochondrial antibody number 5. | 1978 | 49 |
| 9 | 1997 | 46 | |
| 10 | 1988 | 44 | |
| 11 | 1995 | 44 | |
| 12 | 1997 | 43 | |
| 13 | 1993 | 40 | |
| 14 | 1994 | 32 | |
| 15 | 1994 | 31 | |
| 16 | 1996 | 28 | |
| 17 | 1987 | 28 | |
| 18 | 1996 | 25 | |
| 19 | 2000 | 25 | |
| 20 | 1991 | 24 |
About M. T. Labro
M. T. Labro is a scholar working on Immunology, Pharmacology, Infectious Diseases, Epidemiology and Molecular Medicine, having authored 59 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (16 papers), Antibiotic Resistance in Bacteria (15 papers), Immune Response and Inflammation (14 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Blood disorders and treatments (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and Pneumonia and Respiratory Infections (6 papers). The work is most often cited by research in Molecular Medicine (215 citations), Microbiology (150 citations), Pharmacology (322 citations), Immunology (386 citations) and Epidemiology (505 citations). M. T. Labro has collaborated with scholars based in France, Morocco and Tunisia. Frequent co-authors include Houria Abdelghaffar, C. Babin-Chevaye, A. Bryskier, El Mostafa Mtairag, J Hakim, Jean‐Claude Homberg, Michel Weber, Muriel Andrieu, Véronique Ollivier and Muriel Amar. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Journal of Chemotherapy, The Journal of Immunology and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.